Gout, hyperuricemia, and Parkinson's disease: A protective effect?

被引：17

作者：

Alonso A. ^{[1
]}

Sovell K.A. ^{[1
]}

机构：

[1] Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454

来源：

Current Rheumatology Reports | 2010年 / 12卷 / 2期

关键词：

Epidemiology; Gout; Parkinson's disease; Review; Uric acid;

D O I：

10.1007/s11926-010-0083-4

中图分类号：

学科分类号：

摘要：

Oxidative stress is potentially involved in the pathogenesis of Parkinson's disease (PD). Serum uric acid, because of its antioxidant effect, might prevent the development of this neurodegenerative disorder. Indeed, a number of epidemiologic studies have consistently reported a strong inverse association between serum uric acid and the risk of PD. The risk of PD is also lower among individuals with gout. In addition, suggestive evidence from clinical studies shows high levels of uric acid as a marker of better prognosis in PD. Future research should determine the mechanisms underlying this association. This, in turn, could be used in the development of new preventive strategies and treatments for PD. © Springer Science+Business Media, LLC 2010.

引用

页码：149 / 155

页数：6

共 30 条

[1]

Gabriel S.E., Michaud K., Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases, Arthritis Res Ther, 11, (2009)

[2]

Feig D.I., Kang D.H., Johnson R.J., Uric acid and cardiovascular risk, N Engl J Med, 359, pp. 1811-1821, (2008)

[3]

Hirtz D., Thurman D.J., Gwinn-Hardy K., Mohamed M., Chaudhuri A.R., Zalutsky R., How common are the "common" neurologic disorders?, Neurology, 68, 5, pp. 326-337, (2007)

[4]

Elbaz A., Moisan F., Update in the epidemiology of parkinson's disease, Curr Opin Neurol, 21, pp. 454-460, (2008)

[5]

Savitt J.M., Dawson V.L., Dawson T.M., Diagnosis and treatment of parkinson disease: Molecules to medicine, J Clin Invest, 116, pp. 1744-1754, (2006)

[6]

Larumbe Ilundain R., Ferrer Valls J.V., Vines Rueda J.J., Et al., Case-control study of oxidative stress and plasma iron metabolism markers in parkinson's disease [in Spanish], Rev Esp Salud Publica, 75, pp. 43-53, (2001)

[7]

Annanmaki T., Muuronen A., Murros K., Low plasma uric acid level in parkinson's disease, Mov Disord, 22, pp. 1133-1137, (2007)

[8]

Andreadou E., Nikolau C., Gournaras F., Et al., Serum uric acid levels in patients with parkinson's disease: Their relationship to treatment and disease duration, Clin Neurol Neurosurg, 111, pp. 724-728, (2009)

[9]

Ahlskog J.E., Uitti R.J., Low P.A., Et al., No evidence for systemic oxidant stress in parkinson's or alzheimer's disease, Mov Disord, 10, pp. 566-573, (1995)

[10]

Davis J.W., Grandinetti A., Waslien C.I., Et al., Observations on serum uric acid levels and the risk of idiopathic parkinson's disease, Am J Epidemiol, 144, pp. 480-484, (1996)

← 1 2 3 →